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The study was conducted between September 2012 and M y 2013, to determine the frequency of 
hepatitis B virus carriage among apparently healthy individuals of different blood groups and haemoglobin 
genotypes. Nine hundred and eighty (980) students ad staff comprising of males and females, aged 15-39 
years, participated in the study. Five millilitres of blood sample was collected, 3 ml of which was put in a plain 
container for hepatitis B screening, while 2 ml was put into anti-coagulated container for blood group and 
haemoglobin electrophoresis. Using hepatitis B immunoassay strip (Global source, Shenyang LTH Tech, 
China), hepatitis status of each subject was determin d; blood group was determined using tube agglutinatio  
method, while haemoglobin genotype was determined by electrophoresis method. The overall sero-prevalence 
recorded in this study was 6.94%. Assessing the infection rate with respect to age and blood group, 15-19 year 
bracket has the highest rate 18(1.86%) and it was recorded among blood group individuals. Statistical analysis 
by Chi Square showed no significant difference in the rate of hepatitis B carriage with respect to ABO blood 
grouping system   (X2 = 0.3412, P> 0.05). The distribution of viral carri ge rate among the Rhesus D positive 
individuals was statistically higher than the rate in Rhesus D negative subjects (X2 = 4.321,   P < 0.05). Higher 
frequency of the carriage was also recorded among the females 37(3.78%) than the males 31(3.16%). While Hb 
– AA individuals had the highest rate of 50(5.10%) of carriage, there was no case of infection among 
individuals with Hb – SS, Hb – SC and Hb –CC. Statistically, Chi Square test showed no significant difference 
in the rate of hepatitis B infection in relation to haemoglobin genotype (X2 = 1.201, P> 0.05). In conclusion, 
individuals with pathological genotypes (Hb – SS, Hb – SC, and Hb – CC) were hepatitis B sero-negative. 
Also, the study recorded a significant link between hepatitis B and Rhesus D blood group system. Further 
investigation is recommended using more sensitive techniques to corroborate the present findings. 
© 2014 International Formulae Group. All rights reserved. 
 




The term hepatitis virus is usually used 
to describe infections caused by agents whose 
primary tissue of tropism is the liver (Beasley 
and Hwang, 1999; Lok, 2002). Hepatitis B 
virus is one of the major health priorities. An 
estimated 600,000 people die each year 
because of the acute or chronic consequences 
of hepatitis B while most of the cases are 
asymptomatic and more than 350 million 
people are chronic carriers of the virus world-
wide. When tests of carriage of HBV became 
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widely available, chronic carrier states were 
found in many regions of the world 
(Lavanchy, 2004; Shepard et al., 2006). 
Hepatitis B virus is a common cause of 
liver cirrhosis and hepato-cellular carcinoma 
(Li et al., 2012) and it is endemic in 
developing region with large populations such 
as in Sub–Saharan Africa (Jinlin et al., 2005). 
In some tropical countries, a report indicated 
that hepatitis B prevalence ranged between 
5% and 15% while the global estimate of 
people with the infection  is about 2 billion 
(Mandell, 2009; Abdulazzez et al., 2008).  It 
was also reported that 15-40% of HBV 
infected patients develop complications 
(WHO, 2000) and 500, 000 to 1.2 million 
people die of HBV infection annually (Lok, 
2002; Chuckwurah and Nueli, 2006). 
Haemoglobin genotype is defined as 
variants of haemoglobin when blood is 
subjected to electric field. Hb – A is the 
fastest of the commonest variants, followed by 
Hb – S and Hb – C in that other. Genotype 
can be pathological, trait or normal depending 
on the types of haemoglobin inherited. 
Inheritance of similar pathological 
haemoglobin from both parents lead to 
homozygous pathological haemoglobin such 
as Hb – SS and Hb – CC while inheritance of 
dissimilar pathological haemoglobin from 
both parents gives rise to heterozygous 
pathological haemoglobin such as Hb – SC 
and Hb – SD. A trait is otherwise known as 
carrier. It is a heterozygous combination of 
pathological haemoglobin from one patient 
and normal haemoglobin from the other such 
as Hb – AS and Hb – AC. Inheritance of 
normal haemoglobin from each of the parents 
result to Hb – AA. 
ABO blood group system was the first 
human blood group system to be discovered 
(Abdulazeez et al., 2008). It is made up of A 
and B antigens that determine the types of the 
blood group. Individuals with both antigens in 
their red blood cells are said to belong to 
blood group AB, while those with only A 
antigen belong to group A and those with B 
antigen only are in group B where as 
individuals with neither of the antigens belong 
to blood group O. Rhesus blood group is 
another crucial blood group system next to 
ABO system in blood transfusion. Rhesus D is 
more prevalent than Rhesus C and E in 
tropical countries (Abdulazeez et al., 2008; 
Ukaejiofo and Nubila, 2006). Individuals with 
dominants Rhesus D antigen in their blood are 
said to be Rhesus D positive while those with 
recessive antigen are Rhesus D negative. 
Many reports in the past had indicated 
links between some diseases and blood group 
systems (Mandell, 2009; Li et al., 2012). In a 
research conducted by Behal et al. (2010), 
ABO blood group system was linked with 
hepatocellular carcinoma while Wang et al. 
(2012) reported an association between blood 
group A, hepatitis B and cancer of the 
pancreas.  In another study, stomach cancer 
was reported to have a higher prevalence 
among blood group A population than the rest 
of ABO blood groups (Mahoney, 1999). 
Similarly blood group O individuals were 
reported to be more prone to peptic ulcer 
diseases due to lack of N – acetyl- glucosamin 
necessary for the development of mucosa 
lining of their alimentary canal (Omoregie et 
al., 2002). This study therefore, was focused 
on assessment of any link between hepatitis B 
virus, blood group systems and haemoglobin 
genotypes. 
 
MATERIALS AND METHODS 
Study population 
The study was conducted between 
September 2012 and May 2013 on nine 
hundred and eighty  samples from apparently 
healthy students and staff of Kwara State 
University, Malete, who were on in the 
routine medical check – up at the University's 
Health Centre. The subjects composed of 
males and females aged 15 – 39 years. Before 
sample collection, approval was obtained 
from Research and Ethics committee of 
Kwara State University in accordance with 
Helsinki Declaration Guidelines. Consent of 
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all participants was sought and obtained as 
only volunteers participated in the study. 
 
Collection, handling and processing of 
specimens 
Five millilitres of blood samples were 
collected from each of the study subjects. 
Three millilitres of the specimen were put in 
plain specimen containers for Hepatitis B 
virus screening while the remaining 2 
millilitres was put in Ehtylene Diamine– 
Tetra-acetic Acid (EDTA) containers and 
mixed properly to prevent clotting before 
using for grouping and genotype. Commercial 
Hepatitis B rapid chromatographic 
immunoassay strip (Global source, Shenyang 
LTH Tech, China 130033) was employed in 
the study. 
 The clotted blood samples were spun 
at 2,000 revolutions per minute for 2 minutes, 
sera collected and screened for hepatitis B 
surface antigen using the procedure described 
by the manufacturer as follows: Each test strip 
was dipped into a serum sample up to the 
marked level on the strip, removed 
immediately and kept on the laboratory work 
bench for two minutes before reading and 
interpretation. Presence of double line on the 
strip indicates positive result while single line 
implies absence of hepatitis B surface antigen 
(Negative). The anti–coagulated blood was 
used for blood grouping and haemoglobin 
electrophoresis. Tube method of grouping was 
employed but all cases of negative results 
were further confirmed by another tube 
method using Anti–human globulin (AHG) as 
previously described technique by 
Cheesbrough (2002). Haemoglobin genotype 
of the samples was determined using 
electrophoresis machine (DY 300, India). The 
procedure for routine electrophoresis 
described by Ochei and Kolhatkar (2007) and 






Data obtained from the tests were 
analyzed with SPSS version 17 software of 
computer (SPSS Inc. USA). The test for 
significance was performed using Chi Square 
statistical analysis for hepatitis B sero-
distribution in relation to haemoglobin 
genotypes and blood groups. Statistical 
difference was interpreted based on 95% 
confidence level (P = 0.05).  
 
RESULTS 
Table 1 depicts the distribution of 
Hepatitis B infection among ABO blood 
group system in relation to age and gender of 
study subjects while Figure 1 indicates the 
overall frequency of the HBV carriage in 
relation to blood group. Highest sero-
prevalence of HBV 38(3.88%) was recorded 
within the age bracket 15 – 19 years while no 
HBV infection was recorded within the age 
30–39 years. Break down of the infection rate 
with respect to blood group within the age 
group 15 – 19 years shows highest 18(1.83%) 
prevalence among blood group O while the 
least 1(0.11%) was recorded among the 
subjects with blood group AB. On the overall, 
out of 68 recorded seropositive cases in this 
study, 36(3.68%), 15(1.53%), 14(1.43%) and 
3(0.31%) were recorded among subjects with 
blood group O, B, A and AB respectively. 
Statistical analysis by Chi square shows no 
significant difference in the frequency of 
HBV infection with respect to ABO blood 
group (X2=0.2171, P>0.05).  Similarly, the 
overall distribution of Hepatitis B virus 
among female was 37(3.78%) while it was 
31(3.16%) among their male counterparts.  
The frequency of Hepatitis B virus in 
Rhesus D blood group system with respect to 
age and gender is as shown in Table 2. Out of 
the entire 68 seropositive HBV recorded, 
61(6.22%) individuals were Rhesus D positive 
and 7(0.71%) were recorded in Rhesus D 
negative. The highest 36(3.68%) rate of HBV 
was recorded among Rhesus D positive 
subjects within 15 – 19 age bracket where as 
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the highest rate of the infection among Rhesus 
D negative was recorded within the age group 
20–24 years. The frequency of the 
seroprevalence of HBV among Rhesus D 
positive individuals is statistically higher than 
the prevalence Rhesus D negative subjects (X2 
= 4.321,  P<0.05). 
The overall distribution of the infection 
in relation to genotype is as shown in Figure 
1. Out of 31(3.16%) males sero-positive with 
hepatitis B virus, 23(2.35%) 6(0.61%) and 
2(0.22%) subjects belong to Hb – AA, Hb – 
AS, and Hb – AC respectively similarly, of 
37(3.78%) females seropositive HBV, 
27(2.76%) belongs to Hb – AA 8(0.74%) to 
Hb – AS, while 2(0.22%) belong to Hb – AC 
respectively. There was no case of 
seropositive reaction among individuals with 
Hb – SS, Hb – SC and Hb – CC. Statistically, 
Chi. Square test showed no significant 
difference in the distribution of the viral 




Table 1: Distribution of Hepatitis B infection among ABO blood groups by age and gender. 
 
Age Infection rate (%)    ABO Blood Groups system (%) 
Group n= 980 A B AB O 
15 – 19 38(3.78) 9(1.00) 10(1.1) 1(0.10) 18(1.84) 
20 – 24 27(2.76) 5(0.91) 4(0.48) 1(0.10) 17(1.73) 
25 – 29 3(0.31) 0(0.00) 1(0.10) 1(0.10) 1(0.1) 
30 – 34 0(0.00) 0(0.00) 0(0.00) 0(0.00) 0(0.00) 
35 – 39 0(0.00) 0(0.00) 0(0.00) 0(0.00) 0(0.00) 
Total Gender 68(6.94) 14(1.43) 15(1.53) 3(0.31) 36(3.69) 
Male 31(3.16) 6(0.61) 7(0.71) 1(1.1) 17(1.73) 
Female 37(3.78) 8(0.82) 8(9.82) 2(0.22) 19(1.99) 
Total 68(6.94) 14(1.43) 15(10.53) 3(1.32) 36(3.72) 




Table 2: Frequency of Hepatitis B viral infection in Rhesus D blood group system according to age 
and gender. 
 
Age Group Infection rate (%) Rhesus D Positive (%) Rhesus D Negative (%) 
15 – 19 38(3.78) 36(3.37) 2(0.22) 
20 – 24 27(2.76) 23(2.35) 4(0.43) 
25 – 29 3(0.31) 2(0.22) 1(0.11) 
30 – 34 0(0.00) 0(0.00) 0(0.00) 
35 – 39 0(0.00) 0(0.00) 0(0.00) 
Total Gender 68(6.94) 61(6.22) 7(0.72) 
Male 31(3.16) 29(2.96) 2(0.22) 
Female 37(3.78) 32(3.29) 5(0.51) 
Total 68(6.94) 61(6.22) 7(0.72) 
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Although there are several methods 
such as radioimmunoassay, Enzyme Linked 
Immunosorbent Assay (ELISA) and 
Polymerase Chain Reaction (PCR) that can be 
employed to detect hepatitis B surface antigen 
in clinical specimens, these methods appear 
expensive to acquire in most laboratories in 
developing countries. Rapid immunoassay 
technique, being more frequently employed in 
this part of the globe, was therefore used for 
this study.    
Our findings revealed a worrisome rate 
(6.94%) of hepatitis B infection among 
apparently healthy individuals in a university 
community. This rate calls for concern, 
considering the fact that the result was 
obtained within an academic institution that is 
expected to be more enlightened on health 
education and prevention against 
communicable and non–communicable 
diseases. In line with our result was that of 
Jinlin et al. (2005) that recorded a high 
seroprevalence of HBV of 7.0% among 
asymptomatic carriers. However, a low 
seroprevalence rate of 2.14% was reported by 
Alavian et al. (2008) and Nokhadian et al. 
(2009) in Iran. The reason for the variation in 
the findings could probably be due to 
differences in geographical region, methods of 
viral detection and exposure to the virus. 
While a rapid chromatographic immunoassay 
strip was used in this present study, Enzyme 
Linked Immunosorbent Assay (ELISA) was 
employed in the previous study.   However, 
the reason for the high rate of hepatitis B 
infection recorded in this study especially 
within age bracket 15-29 years could not be 
ascertained but a previous finding by Yusuf et 
al. (2009) had associated this age group with 
hepatitis B and HIV infections.  
Judging from the present findings, 
Rhesus D negative blood group most 
especially those that are in blood group O 
have lower rate of hepatitis B infection while 
Rhesus D positive individuals recorded higher 
rate. The reason for this scenario is not certain 
but could probably be due to lack of A and or 
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B antigens in the blood and  ability of the 
group to stimulate more anti-viral antibodies 
in Rhesus D negative individuals hence 
prevent the viral infection. This observation is 
in line with findings of Abdulazeez et al. 
(2008) conducted on association between 
ABO blood group system and HIV infection 
in which HIV rate was significantly higher 
among Rhesus D positive than Rhesus D 
negative individuals.  
The age related distribution of the 
infection revealed that as the age of the 
subjects increases, the frequency of infection 
decreases with the highest rate (3.88%) 
recorded within the youngest age bracket 15 – 
19 years, followed by 2.76% in 20 – 24 years 
age bracket while no infection was recorded 
among the subjects within age – group 30 – 34 
years and 35–39 years. The possible 
explanation for this trend is probably that at 
younger age the subjects could be more 
sexually active than in the old age making the 
younger group more at high risk than their 
older counterparts. Statistically, however, 
there was no significant difference in the 
distribution of the infection by age (X2 
=0.9430, P> 0.05). 
Similarly, when the frequency of the 
carriage of HBV was assessed in relation to 
gender, higher rate of (3.78%) was recorded 
among the females than their male 
counterparts with 3.16% seroprevalence. 
According to the report of Yusuf et al. (2009), 
in a similar work, the variation could probably 
be attributed to difference in anatomical 
structure of genito–urinary tract which makes 
females more pre-disposed to sexually 
transmitted infections. However, the study 
showed no significant difference statistically 
in the distribution of the infection according to 
gender (X2= 0.5532, P>0.005).   
 
Conclusion 
 In the overall, the sero-prevalence of 
hepatitis B infection among asymptomatic 
individuals in the university community 
investigated was 6.94%. This rate was quite 
significant and calls for concerted efforts in 
creating awareness that will prevent further 
spread. Interestingly, individuals with 
pathological genotypes (Hb – SS, Hb – SC, 
and Hb – CC) were not affected by the virus. 
Further investigation is therefore suggested to 
document any scientific explanation for this 
scenario. Lastly, the study recorded a 
significant link between hepatitis B and 
Rhesus D blood group system. We 
recommend further studies using more 
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